Dual effect of chemokine CCL7/MCP-3 in the development of renal tubulointerstitial fibrosis.
暂无分享,去创建一个
J. Schanstra | P. Heeringa | J. Pradère | I. Charo | J. Klein | J. Bascands | Julien Gonzalez | B. Buffin-Meyer | J. Duchêne | J. Maoret | D. Calise | S. Mouttalib | C. Delage | B. S. van der Veen | Christine Delage
[1] Takahiro Matsumoto,et al. Differential role of regulatory T cells in early and late stages of pulmonary fibrosis. , 2013, Immunobiology.
[2] Gang Xu,et al. CD4+ T Lymphocytes, Especially Th2 Cells, Contribute to the Progress of Renal Fibrosis , 2012, American Journal of Nephrology.
[3] Yi Fang,et al. The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[4] G. Arteel,et al. Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism , 2012, Experimental biology and medicine.
[5] J. Renauld,et al. Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis. , 2011, American journal of respiratory and critical care medicine.
[6] R. Mason,et al. Interstitial fibrosis is associated with increased COL1A2 transcription in AA-injured renal tubular epithelial cells in vivo. , 2011, Matrix biology : journal of the International Society for Matrix Biology.
[7] Qincheng He,et al. CD4+CD25+Foxp3+ Regulatory T Cells Depletion May Attenuate the Development of Silica-Induced Lung Fibrosis in Mice , 2010, PloS one.
[8] Liping Huang,et al. Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. , 2010, Kidney international.
[9] M. Dockrell,et al. Connective Tissue Growth Factor-(CTGF, CCN2) – A Marker, Mediator and Therapeutic Target for Renal Fibrosis , 2009, Nephron Experimental Nephrology.
[10] Youhua Liu,et al. Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy. , 2009, Kidney international.
[11] J. Schanstra,et al. Delayed Treatment with Plasminogen Activator Inhibitor-1 Decoys Reduces Tubulointerstitial Fibrosis , 2009, Experimental biology and medicine.
[12] Liping Huang,et al. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. , 2009, Journal of the American Society of Nephrology : JASN.
[13] V. Aidinis,et al. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.
[14] B. Thornhill,et al. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. , 2009, Kidney international.
[15] M. T. Grande,et al. Fibroblast activation and myofibroblast generation in obstructive nephropathy , 2009, Nature Reviews Nephrology.
[16] D. Abraham,et al. Cross-talk between MCP-3 and TGFbeta promotes fibroblast collagen biosynthesis. , 2009, Experimental cell research.
[17] J. Schanstra,et al. Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] T. Yoo,et al. MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells. , 2008, American journal of physiology. Renal physiology.
[19] K. Hamaoka,et al. Macrophage Phenotype and Renal Fibrosis in Obstructive Nephropathy , 2008, Nephron Experimental Nephrology.
[20] F. Sallusto,et al. Chemokines and leukocyte traffic , 2008, Nature Immunology.
[21] M. Mack,et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. , 2007, The Journal of clinical investigation.
[22] I. Shiraishi,et al. MMP-2 inhibition reduces renal macrophage infiltration with increased fibrosis in UUO. , 2007, Biochemical and biophysical research communications.
[23] P. McCarthy,et al. Monocyte Chemotactic Protein‐3 Is a Myocardial Mesenchymal Stem Cell Homing Factor , 2007, Stem cells.
[24] R. Ransohoff,et al. The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.
[25] Jean-Loup Bascands,et al. Obstructive nephropathy: insights from genetically engineered animals. , 2005, Kidney international.
[26] I. Shiraishi,et al. Adoptive transfer of macrophages ameliorates renal fibrosis in mice. , 2005, Biochemical and biophysical research communications.
[27] N. Wahab,et al. TGF-β1-Induced Connective Tissue Growth Factor (CCN2) Expression in Human Renal Proximal Tubule Epithelial Cells Requires Ras/MEK/ERK and Smad Signalling , 2005, Nephron Experimental Nephrology.
[28] D. Harris,et al. The role of tubulointerstitial inflammation. , 2005, Kidney international. Supplement.
[29] B. Antus,et al. Inhibition of Matrix Metalloproteinases During Chronic Allograft Nephropathy in Rats , 2005, Transplantation.
[30] Yasunori Iwata,et al. Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. , 2004, Journal of the American Society of Nephrology : JASN.
[31] D. Abraham,et al. Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouse. , 2003, Arthritis and rheumatism.
[32] P. Carmeliet,et al. Urokinase receptor modulates cellular and angiogenic responses in obstructive nephropathy. , 2003, Journal of the American Society of Nephrology : JASN.
[33] M. Linton,et al. Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. , 2002, The Journal of clinical investigation.
[34] S. Klahr,et al. Obstructive nephropathy and renal fibrosis. , 2002, American journal of physiology. Renal physiology.
[35] H. Anders,et al. Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. , 2001, Journal of the American Society of Nephrology : JASN.
[36] A. Zlotnik,et al. Chemokines: a new classification system and their role in immunity. , 2000, Immunity.
[37] R. Doms,et al. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. , 1999, Blood.
[38] F. Thaiss,et al. Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-β , 1999 .
[39] A. Mantovani,et al. The chemokine system: redundancy for robust outputs. , 1999, Immunology today.
[40] A. Luster,et al. Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.
[41] S. Phan,et al. Costimulation of Fibroblast Collagen and Transforming Growth Factor β1 Gene Expression by Monocyte Chemoattractant Protein-1 via Specific Receptors* , 1996, The Journal of Biological Chemistry.
[42] Margaret Jones,et al. Detection of T and B cells in many animal species using cross-reactive anti-peptide antibodies. , 1993, Journal of immunology.
[43] G. Opdenakker,et al. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family , 1992, The Journal of experimental medicine.
[44] R. Atkins,et al. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. , 2006, Kidney international.
[45] W. Qi,et al. The renal cortical fibroblast in renal tubulointerstitial fibrosis. , 2006, The international journal of biochemistry & cell biology.
[46] J. Van Damme,et al. Monocyte chemotactic protein-3. , 2001, European cytokine network.
[47] F. Thaiss,et al. Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-beta. , 1999, Kidney international.
[48] M. Haine,et al. Van Damme A. , 1986 .